ASLAN001 in Combination With Oxaliplatin and Capecitabine or Oxaliplatin and 5-FU With Leucovorin

NCT02435927 · clinicaltrials.gov ↗

PHASE1

Phase

UNKNOWN

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Solid Tumors

Interventions

DRUG: ASLAN001+ CAPOX (Oxaliplatin, capecitabine)
DRUG: ASLAN001 + mFolfox6 (5-FU, leucovorin)

Sponsor

National Cancer Centre, Singapore

Collaborators

[object Object]
[object Object]